This is a preview of subscription content, log in via an institution to check access.
Notes
see PharmacoEconomics & Outcomes News 743 p34; 809188930
Reference
NICE. NICE recommends abiraterone for prostate cancer. Media Release : 21 Mar 2016. Available from: URL: http://www.nice.org.uk
Rights and permissions
About this article
Cite this article
Abiraterone recommended for prostate cancer by NICE. PharmacoEcon Outcomes News 749, 33 (2016). https://doi.org/10.1007/s40274-016-2920-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2920-9